Annexin A2 also promotes immune escape of hepatocellular carcinoma, by upregulation of immune checkpoint molecules, and decreased expression of effector factors, including perforin, granzyme B (GZMB), interferon-γ, and TNF-α [17]. The gene discussed is GZMB; the disease is hepatocellular carcinoma.